Evidence map›Paper›PMID 19535238›Full record

ReviewCurrent opinion in cell biology2009

The signaling mechanisms of syndecan heparan sulfate proteoglycans.

Kathleen Lambaerts, Sarah A Wilcox-Adelman, Pascale Zimmermann

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in cell biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 192 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Fibulin-4 and latent-transforming growth factor beta-binding protein-4 interactions with syndecan-2 and syndecan-3 are required for elastogenesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. PDZ scaffolds regulate extracellular vesicle production, composition, and uptake.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Kathleen LambaertsLaboratory for Signal Integration in Cell Fate Decision, Department of Human Genetics, K.U. Leuven, Herestraat 49, Leuven, Belgium.
Sarah A Wilcox-Adelman
Pascale Zimmermann
Boston Biomedical Research Institute · USKU Leuven · BE

Funding

SYNDECAN-4 SIGNALING IN CELL-MATRIX INTERACTIONSR01HD037490 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI GOETINCK, PAUL F · 1999 to 2008
$3.3M
NICHD NIH HHS HD 037490NICHD NIH HHS R01 HD037490
6 · The paper itself

Abstract

Syndecans are membrane proteins controlling cell proliferation, differentiation, adhesion, and migration. Their extracellular domains bear versatile heparan sulfate chains that provide structural determinants for syndecans to function as coreceptors or activators for molecules like growth factors and constituents of the matrix. Syndecans also signal via their protein cores and their conserved transmembrane and cytoplasmic domains. The direct interactions and signaling cascades they support are becoming better characterized. These interactions are regulated by phosphorylation, induced clustering and shedding of the syndecan extracellular domain. Moreover evidence is emerging that syndecans concentrate in unconventional lipid domains and might govern novel vesicular trafficking pathways. Here we focus on recent findings that refine our understanding of the complex structure-function relationships of these cellular effectors.

Indexed as

Signal TransductionAnimalsEndocytosisHeparan Sulfate ProteoglycansHumansProtein TransportStructure-Activity RelationshipSyndecansHeparan Sulfate ProteoglycansSyndecans

Identifiers

PMID19535238
PMCPMC2758656
OpenAlexW1963709999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.